Atients with visual impairment had a higher prevalence of DM and

Матеріал з HistoryPedia
Перейти до: навігація, пошук

Sex, BMI, smoking, duration of dialysis, left ventricular E statistics were used to describe the sociodemographic characteristics of doctors hypertrophy on electrocardiogram, hemoglobin, corrected calcium, phosphorus, triglyceride, low-density lipoprotein (LDL)-cholesterol, hs-CRP levels, and HD adequacy were not significantly different between patients without visual impairment and those with visual impairment. There was no difference in the use of b-blocker at the time of enrollment between the 2 groups. Patients with visual impairment had higher systolic BP and iPTH levels and lower diastolic BP, serum albumin, and total cholesterol than patients without visual impairment. The use of ACEi or ARB and the proportion of Medicaid were significantly higher in patients with visual impairment than patients without visual impairment. The proportion of higher education was significantly higher in patients without visual impairment than patients with visual impairment. Following propensity score matching, standardized mean difference were calculated within 0.2, except BMI and health insurance, between 2 groups.Clinical Factors Influencing Visual Impairment in Hemodialysis PatientsTable 2 shows the clinical and laboratory risk factors influencing visual impairment in HD patients. In the univariable analysis, age, systolic and diastolic BP, DM, cardiovascular disease, serum creatinine, serum albumin, serum phosphorus, total cholesterol and iPTH, health insurance, and education status significantly influenced visual impairment in HD patients. In the multivariable logistic analysis, the comorbid condition of DM was the most significant risk factor for visual impairment (odds ratio [OR] 2.777, 95 confidence interval [CI] 2.170?.553, P